Kenneth Harris

Title: Innovations by Kenneth Harris in Stem Cell Therapy

Introduction

Kenneth Harris is a prominent inventor based in Los Angeles, California, renowned for his contributions to the medical field, particularly in stem cell therapy. With a total of three patents to his name, Harris is at the forefront of innovations that aim to enhance treatment methodologies in cardiovascular disorders.

Latest Patents

Harris's latest patent, titled "Rapid infusion of autologous bone marrow derived stem cells," presents a groundbreaking method and composition for the aspiration, processing, testing, and infusion of bone marrow-derived stem cells. This invention focuses on providing an adjuvant treatment for cardiovascular disorders. The patented method emphasizes rapid point-of-care environments where the centrifugal fractionation and optically monitored separation of bone marrow yield cellular products with the desired concentration and viscosity, thus accelerating the delivery of therapeutic agents to patients.

Career Highlights

Kenneth Harris is associated with Cesca Therapeutics, Inc., a company dedicated to the development of stem cell-based regenerative medicine. His expertise in the field has led to significant advancements in the way stem cells are processed and infused, directly impacting patient care and treatment outcomes.

Collaborations

Throughout his career, Harris has collaborated with esteemed colleagues, including Dalip Sethi and Venkatesh Ponemone. Together, they have worked on innovative projects that push the boundaries of current medical practices in stem cell therapy.

Conclusion

Kenneth Harris's contributions to the field of stem cell research and therapy are noteworthy, particularly through his innovative patents that enhance the efficacy of treatment for cardiovascular disorders. His continued work at Cesca Therapeutics, Inc. and collaborations with fellow experts highlight the importance of teamwork in driving advancements in medical technology and improving patient care.